RhAPPcast

FAQ: How Should Treatment Duration be Approached After Remission or Low Disease Activity in SLE?

2:49

In this FAQ video, Heather Finlayson, PA-C, discusses how treatment duration should be approached after achieving remission or low disease activity in systemic lupus erythematosus (SLE). As treatment options continue to expand and more patients achieve sustained disease control, questions about when and how to taper therapy have become increasingly important.

This educational discussion reviews…